Back to Search
HAZEL MANZANO, MD
MD
Internal Medicine Physician
NPI: 1801889316Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
Research & Publications (8)
Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
PMID 15850907·Int J Radiat Oncol Biol Phys·2005
3-trial
Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
PMID 16214045·Eur J Cancer·2005
4-observational
Phase II study of irinotecan (CPT-11) administered every 2 weeks as treatment for patients with colorectal cancer resistant to previous treatment with 5-fluorouracil-based therapies: comparison of two different dose schedules (250 and 200 mg/m2) according to toxicity prognostic factors.
PMID 15457123·Anticancer Drugs·2004
3-trial
Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider.
PMID 15015667·J Neurooncol·2004
5-case
Toxicokinetics of cyanide in rats, pigs and goats after oral dosing with potassium cyanide.
PMID 12799772·Arch Toxicol·2003
4-observational
Does prolonged cyanide exposure have a diabetogenic effect?
PMID 11308117·Vet Hum Toxicol·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 676 N SAINT CLAIR ST, SUITE 2300
CHICAGO, IL 60611 - Phone
- (312) 926-6000
Quick Facts
- NPI
- 1801889316
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile